Stomach Cancer Trial, Recruiting NCT04943484 Sponsor: Niguarda Hospital Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT04943484
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People who have been diagnosed with stomach cancer (specifically a type called adenocarcinoma) in the upper, middle, or lower part of the stomach, confirmed by a tissue sample (biopsy) before surgery
  • People whose cancer is at an advanced local stage but has not spread to distant parts of the body, and where surgery to remove part or all of the stomach is considered safely possible using keyhole (laparoscopic or robotic) techniques
  • People whose scans and surgical assessments show the cancer has not spread to distant organs and has not grown directly into nearby organs such as the pancreas or spleen
  • People who have given written agreement to take part in the trial

Who may not be able to join:

  • People who are pregnant or breastfeeding
  • People who have had previous surgery on the upper abdomen (though prior keyhole gallbladder removal is generally permitted — confirm with trial site)
  • People who have previously had part or all of the stomach removed, or certain previous stomach procedures performed through an endoscope
  • People with a known allergy to iodine-based agents
  • People whose cancer is located at the junction between the food pipe (oesophagus) and the stomach
  • People for whom surgeons plan a type of operation involving the chest, an extended removal of the stomach from below the diaphragm, or removal of only the upper portion of the stomach
  • People who have received chemotherapy before this trial (except standard chemotherapy given as part of treatment for this stomach cancer), or previous radiotherapy to the area

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pietro M Lombardi, MD, Division of Minimally Invasive Surgical Oncology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda

Phone: +39026444

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Niguarda Hospital
Registry
ClinicalTrials.gov
Start date
1 January 2022
Est. completion
31 August 2024

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Surgical conduct

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov